0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Improving Patient Care |

Automated Review of Electronic Health Records to Assess Quality of Care for Outpatients with Heart Failure

David W. Baker, MD, MPH; Stephen D. Persell, MD, MPH; Jason A. Thompson, BA; Neilesh S. Soman, MD, MBA; Karen M. Burgner, MD; David Liss, BA; and Karen S. Kmetik, PhD
[+] Article and Author Information

From Northwestern University, Chicago, Illinois.


Acknowledgment: The authors thank Heidi Bossley for technical assistance.

Grant Support: This project was supported in part by grant number 5 U18 HS013690 from the Agency for Healthcare Research and Quality.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: David Baker, MD, MPH, 676 North St. Clair Street, Suite 200, Chicago, IL 60611-2927; e-mail, dwbaker@northwestern.edu.

Current Author Addresses: Drs. Baker, Persell, Soman and Mr. Thompson and Mr. Liss: Feinberg School of Medicine, Northwestern University, 676 North St. Clair Street, Suite 200, Chicago, IL 60611.

Dr. Burgner: Northwestern Memorial Hospital, 210 East Huron Road, Chicago, IL 60611.

Dr. Kmetik: American Medical Association, 515 State Street, Chicago, IL 60610.


Ann Intern Med. 2007;146(4):270-277. doi:10.7326/0003-4819-146-4-200702200-00006
Text Size: A A A

Five hundred seventeen patients met the eligibility criteria (Table 1). Most patients had codes for heart failure recorded in 2 or more locations (that is, encounter diagnosis, problem list, or medical history). The average number of visits over the previous 18 months was 6.4 (SD, 14.4); 51.3% of patients had underlying coronary artery disease, and 79.5% had a history of hypertension.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
No Title
Posted on April 11, 2007
Linda Fried
VAPHCS
Conflict of Interest: None Declared

II read the article by Baker et al with interest. I was concerned that end-stage renal disease and chronic renal insufficiency were listed as valid exclusions for why individuals are not receiving an ACEI or ARB in heart failure. This is not consistent with current guidelines and AHRQ recommendations state an elevated creatinine is not an exclusion (1). Subgroup analyses of studies do not suggest a lower benefit of ACEI/ARB (2) and as individuals with an elevated creatinine are at higher risk for events, the argument can be made that the potential benefit of ACEI is greater for those with an elevated creatinine.

Linda Fried, MD, MPH VAPHCS Linda.Fried@va.gov

1. http://www.ahrq.org/clinic/cpgarchv.htm 2. Frances CD, Noguchi H, Massie BM, Browner WS, McClellan M. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. Arch Intern Med 2000;160: 1645-2650.

Conflict of Interest:

None declared

The authors reply:
Posted on May 2, 2007
David W. Baker
Feinberg School of Medicine, Northwestern University
Conflict of Interest: None Declared

We agree that severe renal insufficiency is not a contraindication to the use of an ACEI or ARB for patients with heart failure. However, some of these patients will have a severe decline in renal function after starting an ACEI or ARB, requiring discontinuation of treatment. Note that if a patient with severe renal insufficiency tolerates an ACEI or ARB, the patient is represented in both the numerator and the denominator; a physician can "get credit" for treating such a patient successfully but does not "fail" the measure if a patient does not tolerate an ACEI or ARB.

How should performance measures account for comorbidities like renal insufficiency? Performance measures frequently allow patients not receiving guideline-concordant care to be excluded when certain comorbid conditions are present, even if these conditions are not absolute contraindications. Thus, in the case cited above, any patient not prescribed an ACEI or ARB with certain renal failure diagnosis codes would be excluded from the denominator of the quality measure, even though only a subgroup might have sufficient medical justification for withholding treatment. Similarly, heart failure patients not given a beta blocker would be excluded if asthma or chronic obstructive pulmonary disease were present even though only a minority of patients may have bronchospasm so severe as to outweigh the benefits of treatment. This approach is also problematic because listing a condition as an exclusion may be taken to imply that physicians should not even try to initiate a therapy.

Quality measures that rely on these kinds of simplifications are helpful up to a point. When care is only fair, there is room for improvement even among the simple cases. But as care improves, the utility of this kind of measure becomes more limited. To improve quality to very high levels, quality measurement needs to be able to determine if good care is given to more complex patients. In recognition of the problems of using comorbidities as absolute exclusion criteria, the Physician Consortium for Performance Improvement currently recommends using a general "medical reason" exclusion rather than a comprehensive list of relative contraindications or conditions requiring cautious prescribing. When reporting exclusions, physicians are encouraged to explicitly record in the medical record the reason why a therapy is not given. Electronic health record vendors should create standard methods for physicians to easily record justifications for their clinical decisions to improve the accuracy of quality measurement and minimize time burdens.

Conflict of Interest:

None declared

Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)